Recent Finacing
Recent Raise
Base Therapeutics develops base‑editing and cell gene‑therapy platforms centered on AccuBase, offering research and GMP proteins, operating 2,500m² GMP production facility and clinical NK and in vivo liver programs.
Focus Areas
Recent Investors
Funding round
Investor